LUPIN logo

Lupin Limited

F&O
LUPIN·NSE·
2,143.00 -45.40 (-2.07%)
Market Cap98435.67 Cr
PE Ratio18.37
Volume12,74,609
Day High - Low2190.20 - 2137.60
52W High-Low2529.50 - 1875.00
DocStoX Score
6.9/10
Fair
Fair Value
Sign in to see
ROE
29.10%
Strong
P/E
18.37x
Fair
Debt / Equity
0.04
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Fair

Price performance

NIFTY 200NIFTY 500NIFTY MIDCAP 150
Day2138
2190
52W1875
2530
DocStoX take

Supported by quality (8.8) and growth (8.6), but held back by momentum (3.7).

DocStoX score

Low confidence
6.9
/10
Fair
Quality
Excellent
ROE 29.1%
Valuation
Rich
P/E 18.4×
Growth
Strong
Revenue +13.0% 5Y CAGR
Risk
Moderate
D/E 0.04
Momentum
Soft
41% of 52-week range

At a glance

Market Cap
₹98,436 Cr
52W High / Low
₹2530 / ₹1875
Dividend Yield
0.83%
Promoter Holding
46.85%
EPS (TTM)
₹116.65
Book Value
₹491.00

Key highlights

  • Profit compounding 34% a year
  • Capital works hard — ROCE 30%
  • Low leverage — D/E 0.04
4 Positives0 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

LUPIN LIMITED peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.